Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02428712
Title A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Fore Biotherapeutics
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
St. Joseph's Hospital at Orange Orange California 92868 United States Details
Stanford Hospitals and Clinics Stanford California 94305 United States Details
University of Miami Miami Florida 33136 United States Details
Community Health Network Indianapolis Indiana 46011 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Capital Regional Medical Center Jefferson City Missouri 65101 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Baptist Cancer Center Memphis Tennessee 38120 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Texas Children's Hospital (Baylor College of Medicine) Houston Texas 77030 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field